Product Information

ACUVAIL 0.45% OPHTH SOLUTION is a brand product labeled by Allergan, Inc., priced at $10.7367 per EA under NDC 00023350731. Its NADAC has been published 92 times since Jul 17, 2024.

The High Outlier badge above means this manufacturer's average price in the ketorolac tromethamine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ACUVAIL 0.45% OPHTH SOLUTION

ketorolac tromethamine
$10.7367per EA
High Outlier

Strength

4.5 mg/mL

Manufacturer

Allergan, Inc.

NDC

00023350731

Classification

Brand

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Last Updated

4/23/2025

Active Ingredients

KETOROLAC TROMETHAMINE

Approval Type

New Drug (NDA)

FDA Application

NDA022427

On Market Since

8/1/2009

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitor
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for ACUVAIL 0.45% OPHTH SOLUTION has been published 92 times since Jul 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$10.7367 per EA
All-time high$10.7367 (Apr 15, 2026)
All-time low$10.7169 (Jul 17, 2024)
52-week high$10.7367
52-week low$10.7367
Median price$10.7367
Average price$10.7301
Largest weekly change+0.2% (Feb 19, 2025)
Weeks tracked92
Tracking sinceJul 17, 2024

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

+0.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ketorolac tromethamine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of ACUVAIL 0.45% OPHTH SOLUTION?

The current National Average Drug Acquisition Cost (NADAC) for ACUVAIL 0.45% OPHTH SOLUTION, manufactured by Allergan, Inc., is $10.7367 per EA (NDC 00023350731), effective Apr 15, 2026.

How has the price of ACUVAIL 0.45% OPHTH SOLUTION changed over time?

Over the history we have for it, the NADAC for ACUVAIL 0.45% OPHTH SOLUTION has held within roughly two percent of its current level. It has been tracked across 92 weekly CMS publications since Jul 17, 2024.

What are the highest and lowest recorded NADAC prices for ACUVAIL 0.45% OPHTH SOLUTION?

Since Jul 17, 2024, the NADAC for ACUVAIL 0.45% OPHTH SOLUTION has ranged from a low of $10.7169 (Jul 17, 2024) to a high of $10.7367 (Apr 15, 2026), with a median of $10.7367 per EA.

Are there cheaper alternatives to ACUVAIL 0.45% OPHTH SOLUTION?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ACUVAIL 0.45% OPHTH SOLUTION, so no direct lower-cost alternative is listed.

Who manufactures ACUVAIL 0.45% OPHTH SOLUTION?

ACUVAIL 0.45% OPHTH SOLUTION (NDC 00023350731) is labeled by Allergan, Inc., and CMS classifies it as a brand product.